-
Featured
New Strategies for Heart Failure Patients Improves Outcomes
One-third of heart failure patients do not respond to cardiac resynchronization therapy (CRT) | A coordinated care approach at Mass General for heart failure patients improves outcomes.
-
Featured
The Promise of Ventricular-Assist Devices (VADs)
VAD technology is continually improving. Mass General data indicates new VADs improve 5-year survival rates. Trials for the latest generation are under way.
-
Metabolic Cost of Exercise Initiation Higher in HFpEF
Ravi V. Shah, MD, and Gregory D. Lewis, MD, of the Corrigan Minehan Heart Center, and colleagues have defined a new measure, "internal work"—the metabolic cost of initiating movement—that may direct noncardiac therapy for exercise intolerance in patients who have heart failure with preserved ejection fraction.
-
Type 2 Myocardial Infarction Is Prevalent in U.S., Has a Distinct Clinical Profile
Cian P. McCarthy, MD, and James L. Januzzi, Jr., MD, of the Division of Cardiology, and colleagues found in a nationwide U.S. database study that type 2 myocardial infarction (MI) is common and patients have distinctly different characteristics and outcomes than those with type 1 MI.
-
Clinical Diagnostic Tools May Misclassify HFpEF in Dyspnea Patients
Heart failure with preserved ejection fraction (HFpEF) can be challenging to diagnose, and recently risk scores have been developed to aid in diagnosis. For patients with chronic dyspnea, clinician-researchers in the Corrigan Minehan Heart Center sound a note of caution about using these scores including the HFA-PEFF algorithm and H2FPEF score to rule out HFpEF.
-
TRANSFORM HFrEF Study Aims to Improve HF Outcomes
Massachusetts General Hospital Corrigan Minehan Heart Center investigators are transforming the outpatient experience for patients with HFrEF to achieve optimal guideline-directed medical therapy doses and improve outcomes.
Heart Failure contributors
-
James Louis Januzzi, MD
Hutter Family Professor of Medicine, Director, Dennis and Marilyn Barry Fellowship in Cardiology Research
Recent Article
Type 2 Myocardial Infarction Is Prevalent in U.S., Has a Distinct Clinical Profile
-
Thoralf M. Sundt, MD
Chief, Division of Cardiac Surgery, Director, Corrigan Minehan Heart Center
Recent Article
Non–Vitamin K Antagonist Oral Anticoagulants Are Safe for Selected Patients with Postoperative AF
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.Resource links
